Video

Renee Amori from Drexel University College of Medicine: Seeing Improvement In Type 1 Diabetes Treatment

Author(s):

There may not be as many treatment options available for patients with type 1 diabetes but there are still good choices to give them a high quality of life. As the development of the artificial pancreas moves along another even better option is just out of reach.

%jwplayer%

There may not be as many treatment options available for patients with type 1 diabetes but there are still good choices to give them a high quality of life. As the development of the artificial pancreas moves along another even better option is just out of reach.

Calling the development of the artificial pancreas the "holy grail" of the field, Renee Amori, MD, from the Drexel University College of Medicine discussed what its use and that of the insulin pump for type 2 diabetes and what that can mean for the future of the condition.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Viet Le, DMSc, PA-C | Credit: APAC
© 2025 MJH Life Sciences

All rights reserved.